{"gene":"GNAL","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":2012,"finding":"Loss-of-function mutations in GNAL (encoding Gαolf) cause primary torsion dystonia; impaired coupling of Gαolf to downstream signaling was demonstrated using bioluminescence resonance energy transfer (BRET) assays for multiple missense and nonsense mutations.","method":"BRET assay (functional coupling assay), exome sequencing, Sanger sequencing","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1-2 — functional BRET assay with multiple mutations, replicated across multiple subsequent studies","pmids":["23222958"],"is_preprint":false},{"year":2014,"finding":"GNAL missense mutations p.Gly213Ser and p.Ala353Thr impair Gαolf coupling to dopamine D1 receptors, as measured by BRET assay; variants with normal BRET responses (p.Ala311Thr) were classified as benign.","method":"BRET assay measuring Gαolf–D1 receptor coupling","journal":"JAMA neurology","confidence":"High","confidence_rationale":"Tier 1-2 — direct functional assay, orthogonal to initial discovery paper","pmids":["24535567"],"is_preprint":false},{"year":2005,"finding":"GNAL encodes two isoforms of Gαolf via alternative first exons with different CNS expression patterns; both isoforms functionally couple to the dopamine D1 receptor when heterologously expressed in Sf9 cells.","method":"5' RACE, heterologous expression in Sf9 cells, functional coupling assay","journal":"Molecular psychiatry","confidence":"Medium","confidence_rationale":"Tier 2 — functional coupling shown in heterologous system, single lab","pmids":["16044173"],"is_preprint":false},{"year":2017,"finding":"Heterozygous Gnal knockout mice (Gnal+/-) exhibit altered striatal spine morphology and phospho-CaMKIIβ levels, and develop dystonia-like movements after striatal (but not cerebellar) oxotremorine infusion, placing GNAL-dependent cAMP signaling in striatal projection neurons as a key locus for dystonia; muscarinic M1 antagonists prevented these movements.","method":"Heterozygous knockout mouse model, intrastriatal drug infusion, EEG, pharmacological rescue (telenzepine, trihexyphenidyl), operant conditioning, spine morphology analysis","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods, clear loss-of-function phenotype with pharmacological rescue, striatum-specific localization of effect","pmids":["28546310"],"is_preprint":false},{"year":2016,"finding":"A novel GNAL variant (p.F133L) causes elevated basal BRET signal and severely diminished amplitude of response to dopamine stimulation, indicating partial Gαolf loss of function in receptor signal transduction.","method":"BRET assay with dopamine stimulation","journal":"Journal of neurology","confidence":"Medium","confidence_rationale":"Tier 2 — direct functional assay, single lab, single variant","pmids":["26810727"],"is_preprint":false},{"year":2019,"finding":"Gnal haploinsufficiency (Gnal+/- mice) increases catalepsy responses to haloperidol (D2R blocker), causes persistent DNA breaks, decreases cAMP-dependent histone H3 phosphorylation (Ser10), and increases cell death in the striatum; aged Gnal+/- mice show increased global DNA methylation and dendritic structural abnormalities, demonstrating that Gαolf deficiency intensifies the cellular effects of D2R antagonism.","method":"Heterozygous knockout mouse model, behavioral testing (catalepsy), immunostaining (histone H3 pSer10), DNA damage assays, methylation analysis, dendritic morphology","journal":"Experimental neurology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal readouts in a defined genetic model, single lab","pmids":["31034808"],"is_preprint":false},{"year":2024,"finding":"In Gnal+/- rats, A2A receptor (A2AR) total protein levels are increased while adenylyl cyclase 5 (AC5) is reduced; D2 receptor (D2R) protein and its regulatory proteins (RGS9-2, spinophilin, Gβ5, β-arrestin2) are also reduced, and D2R-mediated inhibitory responses in striatal cholinergic interneurons are attenuated, demonstrating a profound disruption of the A2AR/D2R–AC–cAMP cascade downstream of Gαolf loss.","method":"Rat Gnal+/- model, Western blot (receptor and signaling protein quantification), whole-cell patch clamp electrophysiology (D2R-mediated inhibition of cholinergic interneurons)","journal":"Neurobiology of disease","confidence":"High","confidence_rationale":"Tier 1-2 — combined biochemical and electrophysiological approach, multiple orthogonal methods, defined genetic model","pmids":["38182074"],"is_preprint":false},{"year":2024,"finding":"Conditional knockout of Gnal specifically in striatal neurons produces overt dystonia-like motor phenotypes (hindlimb clasping, torticollis, reduced coordination) and increases intrinsic excitability of striatal spiny projection neurons, directly linking striatal Gαolf loss to dystonia via homeostatic increases in neuronal excitability.","method":"Conditional knockout mouse (Gnal fl/fl + Cre), AAV-Cre delivery, motor behavioral testing, ex vivo whole-cell patch clamp electrophysiology","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — well-controlled genetic model with behavioral and electrophysiological readouts, preprint only","pmids":["39253490"],"is_preprint":true},{"year":2025,"finding":"Cell-type-specific conditional deletion of Gnal in D1-receptor-expressing striatal projection neurons (D1-SPNs) confirms Gαolf is required for adenylyl cyclase 5 activation and coupling with D1 receptors; loss in D1-SPNs causes motor deficits and nocturnal hyperactivity but not overt dystonia. Loss in A2A-receptor-expressing SPNs (A2A-SPNs) impairs coupling with A2A receptors and strikingly increases spontaneous locomotion not further enhanced by psychostimulants.","method":"Cell-type-specific conditional knockout mice (D1-Cre and A2A-Cre × Gnal fl/fl), motor behavioral testing, pharmacological challenges (D1 agonists, psychostimulants, caffeine, KW6002), biochemical measurements of adenylyl cyclase 5 activity","journal":"Neurobiology of disease","confidence":"High","confidence_rationale":"Tier 2 — cell-type-specific genetic dissection with multiple pharmacological and behavioral readouts, reciprocal genetic and biochemical validation","pmids":["40902679"],"is_preprint":false}],"current_model":"GNAL encodes Gαolf, a stimulatory G-protein α subunit enriched in striatal projection neurons and olfactory tissue that couples dopamine D1 and adenosine A2A receptors to adenylyl cyclase 5, thereby driving cAMP production; loss-of-function mutations impair this receptor–adenylyl cyclase coupling (shown by BRET and electrophysiological assays), reduce downstream cAMP-dependent signaling and D2R regulatory mechanisms, and increase intrinsic excitability of striatal spiny projection neurons, collectively producing the dystonia motor phenotype associated with DYT-GNAL/DYT25."},"narrative":{"teleology":[{"year":2005,"claim":"Resolving whether GNAL produces a single or multiple protein isoforms revealed two Gαolf variants with distinct CNS expression patterns, both capable of coupling to D1 receptors, establishing isoform diversity as a feature of GNAL signaling.","evidence":"5′ RACE and heterologous expression/functional coupling in Sf9 cells","pmids":["16044173"],"confidence":"Medium","gaps":["Single-lab heterologous system; coupling not confirmed in native striatal neurons","Isoform-specific functional differences in vivo remain undefined","Relative contribution of each isoform to striatal cAMP signaling unknown"]},{"year":2012,"claim":"The central question of whether GNAL mutations cause human dystonia was answered by identifying loss-of-function mutations in dystonia families and demonstrating impaired Gαolf–downstream coupling via BRET, establishing GNAL as a dystonia gene (DYT25).","evidence":"Exome/Sanger sequencing in dystonia families combined with BRET functional assays for multiple missense and nonsense mutations","pmids":["23222958"],"confidence":"High","gaps":["Mechanism by which partial Gαolf loss produces dystonia rather than other movement disorders was unknown","Downstream effector (AC5 vs other cyclases) not yet specified in these assays"]},{"year":2014,"claim":"Extending the BRET-based functional framework to additional GNAL variants enabled discrimination of pathogenic from benign missense changes, confirming that impaired D1R coupling is the shared molecular defect.","evidence":"BRET assay measuring Gαolf–D1 receptor coupling for p.Gly213Ser, p.Ala353Thr (impaired) vs. p.Ala311Thr (normal)","pmids":["24535567"],"confidence":"High","gaps":["Whether coupling defects are equivalent for A2A receptor was not tested","Protein stability vs. coupling defect not distinguished for each variant"]},{"year":2016,"claim":"A variant (p.F133L) showing elevated basal BRET signal with severely diminished dopamine-stimulated response demonstrated that partial loss of function—not just complete loss—of Gαolf receptor coupling is pathogenic.","evidence":"BRET assay with dopamine stimulation for a single novel variant","pmids":["26810727"],"confidence":"Medium","gaps":["Single variant from one laboratory","Whether elevated basal signal reflects constitutive activity or misfolding was not resolved"]},{"year":2017,"claim":"Whether dystonia originates from striatal or cerebellar Gαolf deficiency was resolved: Gnal+/− mice developed dystonia-like movements only after intrastriatal (not cerebellar) muscarinic challenge, and anticholinergics rescued the phenotype, placing the striatum as the critical locus and implicating cholinergic imbalance.","evidence":"Heterozygous Gnal knockout mice, region-specific drug infusion, pharmacological rescue, spine morphology and phospho-CaMKIIβ analysis","pmids":["28546310"],"confidence":"High","gaps":["Pharmacological trigger required to unmask phenotype—spontaneous dystonia not observed in heterozygotes","Cell-type specificity within the striatum not yet resolved"]},{"year":2019,"claim":"Beyond acute signaling, Gαolf haploinsufficiency was shown to produce long-term cellular consequences including persistent DNA breaks, reduced cAMP-dependent histone H3 phosphorylation, increased DNA methylation, and dendritic abnormalities, revealing that chronic Gαolf deficiency causes epigenomic and structural neuronal damage.","evidence":"Gnal+/− mice with immunostaining (H3 pSer10), DNA damage assays, methylation analysis, dendritic morphology, and haloperidol-induced catalepsy","pmids":["31034808"],"confidence":"Medium","gaps":["Causal chain from reduced cAMP to DNA damage and methylation changes not established","Single laboratory study","Whether epigenomic changes are cell-type-specific not determined"]},{"year":2024,"claim":"The full scope of signaling cascade disruption downstream of Gαolf loss was characterized: Gnal+/− rats showed increased A2AR but decreased AC5, D2R, and D2R-associated regulatory proteins (RGS9-2, spinophilin, β-arrestin2), with electrophysiologically confirmed attenuation of D2R-mediated inhibition in cholinergic interneurons.","evidence":"Gnal+/− rat model with Western blot quantification and whole-cell patch-clamp electrophysiology of striatal cholinergic interneurons","pmids":["38182074"],"confidence":"High","gaps":["Whether compensatory A2AR upregulation is functionally protective or maladaptive is unclear","Mechanism of D2R and associated protein downregulation not defined"]},{"year":2025,"claim":"Cell-type-specific deletion resolved the distinct contributions of Gαolf in D1-SPNs versus A2A-SPNs: loss in D1-SPNs impairs D1R–AC5 coupling causing motor deficits without overt dystonia, while loss in A2A-SPNs eliminates A2AR signaling and produces striking hyperlocomotion insensitive to psychostimulants, demonstrating that Gαolf is independently required in both SPN populations for distinct motor functions.","evidence":"Cell-type-specific conditional knockout mice (D1-Cre and A2A-Cre × Gnal fl/fl) with pharmacological challenges and AC5 activity measurements","pmids":["40902679"],"confidence":"High","gaps":["Neither single cell-type deletion fully recapitulated DYT-GNAL dystonia, suggesting combinatorial loss may be required","Whether Gαolf loss in striatal interneurons contributes to dystonia is untested","Circuit-level mechanisms linking SPN excitability changes to dystonic movements remain unresolved"]},{"year":null,"claim":"How partial Gαolf loss in specific striatal cell types converges at the circuit level to produce dystonic movements—and why haploinsufficiency is sufficient in humans but requires pharmacological provocation or complete knockout in rodents—remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model of Gαolf explaining variant-specific coupling defects","Whether Gαolf interacts with additional GPCRs beyond D1R and A2AR in striatum is unexplored","Therapeutic restoration of Gαolf signaling has not been demonstrated in any model"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[0,1,2,4,8]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,1,2,6]}],"pathway":[{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[3,6,7,8]}],"complexes":[],"partners":["DRD1","ADORA2A","ADCY5","RGS9-2","GNB5"],"other_free_text":[]},"mechanistic_narrative":"GNAL encodes Gαolf, a stimulatory G-protein α subunit enriched in striatal projection neurons and olfactory epithelium that couples dopamine D1 and adenosine A2A receptors to adenylyl cyclase 5 to drive cAMP production. Two Gαolf isoforms generated by alternative first exons both functionally couple to the D1 receptor, and loss-of-function mutations impair this coupling as demonstrated by BRET assays across multiple variants [PMID:23222958, PMID:24535567, PMID:16044173]. Gαolf haploinsufficiency in rodent models disrupts the A2AR/D2R–AC5–cAMP signaling cascade, reduces D2R regulatory protein levels, attenuates D2R-mediated inhibitory responses in striatal cholinergic interneurons, and increases intrinsic excitability of spiny projection neurons, with cell-type-specific deletion demonstrating that Gαolf loss in D1-SPNs impairs D1R–AC5 coupling while loss in A2A-SPNs eliminates A2AR-mediated signaling and produces spontaneous hyperlocomotion [PMID:38182074, PMID:40902679, PMID:28546310]. Loss-of-function mutations in GNAL cause primary torsion dystonia (DYT25/DYT-GNAL), with striatal neurons confirmed as the critical locus through region- and cell-type-specific genetic models [PMID:23222958, PMID:28546310, PMID:40902679]."},"prefetch_data":{"uniprot":{"accession":"P38405","full_name":"Guanine nucleotide-binding protein G(olf) subunit alpha","aliases":["Adenylate cyclase-stimulating G alpha protein, olfactory type"],"length_aa":381,"mass_kda":44.3,"function":"Guanine nucleotide-binding protein (G protein) involved as transducer in olfactory signal transduction controlled by G protein-coupled receptors (GPCRs) (By similarity). Contains the guanine nucleotide binding site and alternates between an active, GTP-bound state and an inactive, GDP-bound state (By similarity). Signaling by an activated GPCR promotes GDP release and GTP binding (By similarity). The alpha subunit has a low GTPase activity that converts bound GTP to GDP, thereby terminating the signal (By similarity). Both GDP release and GTP hydrolysis are modulated by numerous regulatory proteins (By similarity). GNAL/G(olf) alpha specifically mediates olfactory signal transduction within the olfactory neuroepithelium and the basal ganglia following GPCRs activation (By similarity). Acts by promoting the specific activation of adenylyl cyclase ADCY3, resulting in increased levels of the signaling molecule cAMP (By similarity)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P38405/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GNAL","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GNAL","total_profiled":1310},"omim":[{"mim_id":"615073","title":"DYSTONIA 25; DYT25","url":"https://www.omim.org/entry/615073"},{"mim_id":"611900","title":"METALLOPHOSPHOESTERASE 1; MPPE1","url":"https://www.omim.org/entry/611900"},{"mim_id":"610142","title":"CENTROSOMAL PROTEIN, 290-KD; CEP290","url":"https://www.omim.org/entry/610142"},{"mim_id":"609147","title":"RIC8 GUANINE NUCLEOTIDE EXCHANGE FACTOR B; RIC8B","url":"https://www.omim.org/entry/609147"},{"mim_id":"606486","title":"CHARGED MULTIVESICULAR BODY PROTEIN 1B; CHMP1B","url":"https://www.omim.org/entry/606486"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Plasma membrane","reliability":"Approved"},{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":63.4}],"url":"https://www.proteinatlas.org/search/GNAL"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P38405","domains":[{"cath_id":"1.10.400.10","chopping":"71-185","consensus_level":"high","plddt":96.9475,"start":71,"end":185},{"cath_id":"3.40.50.300","chopping":"225-372","consensus_level":"high","plddt":94.7621,"start":225,"end":372}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P38405","model_url":"https://alphafold.ebi.ac.uk/files/AF-P38405-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P38405-F1-predicted_aligned_error_v6.png","plddt_mean":93.12},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GNAL","jax_strain_url":"https://www.jax.org/strain/search?query=GNAL"},"sequence":{"accession":"P38405","fasta_url":"https://rest.uniprot.org/uniprotkb/P38405.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P38405/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P38405"}},"corpus_meta":[{"pmid":"23222958","id":"PMC_23222958","title":"Mutations in GNAL cause primary torsion dystonia.","date":"2012","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23222958","citation_count":244,"is_preprint":false},{"pmid":"24535567","id":"PMC_24535567","title":"Mutations in GNAL: a novel cause of craniocervical dystonia.","date":"2014","source":"JAMA neurology","url":"https://pubmed.ncbi.nlm.nih.gov/24535567","citation_count":64,"is_preprint":false},{"pmid":"24151159","id":"PMC_24151159","title":"Rare sequence variants in ANO3 and GNAL in a primary torsion dystonia series and controls.","date":"2013","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/24151159","citation_count":42,"is_preprint":false},{"pmid":"16044173","id":"PMC_16044173","title":"Alternative transcripts and evidence of imprinting of GNAL on 18p11.2.","date":"2005","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/16044173","citation_count":35,"is_preprint":false},{"pmid":"26725140","id":"PMC_26725140","title":"Novel GNAL mutation with intra-familial clinical heterogeneity: Expanding the phenotype.","date":"2015","source":"Parkinsonism & related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/26725140","citation_count":34,"is_preprint":false},{"pmid":"28546310","id":"PMC_28546310","title":"Heterozygous Gnal Mice Are a Novel Animal Model with Which to Study Dystonia Pathophysiology.","date":"2017","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/28546310","citation_count":33,"is_preprint":false},{"pmid":"24500857","id":"PMC_24500857","title":"Heterogeneity in primary dystonia: lessons from THAP1, GNAL, and TOR1A in Amish-Mennonites.","date":"2014","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/24500857","citation_count":30,"is_preprint":false},{"pmid":"11032382","id":"PMC_11032382","title":"Sequence and genomic organization of the human G-protein Golfalpha gene (GNAL) on chromosome 18p11, a susceptibility region for bipolar disorder and schizophrenia.","date":"2000","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/11032382","citation_count":27,"is_preprint":false},{"pmid":"8886169","id":"PMC_8886169","title":"Linkage disequilibrium analysis of G-olf alpha (GNAL) in bipolar affective disorder.","date":"1996","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/8886169","citation_count":25,"is_preprint":false},{"pmid":"27093447","id":"PMC_27093447","title":"GNAL mutation in isolated laryngeal dystonia.","date":"2016","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/27093447","citation_count":23,"is_preprint":false},{"pmid":"23759320","id":"PMC_23759320","title":"Mutation screening of GNAL gene in patients with primary dystonia from Northeast China.","date":"2013","source":"Parkinsonism & related disorders","url":"https://pubmed.ncbi.nlm.nih.gov/23759320","citation_count":18,"is_preprint":false},{"pmid":"31158945","id":"PMC_31158945","title":"The Effect of Globus Pallidus Interna Deep Brain Stimulation on a Dystonia Patient with the GNAL Mutation Compared to Patients with DYT1 and DYT6.","date":"2019","source":"Journal of movement disorders","url":"https://pubmed.ncbi.nlm.nih.gov/31158945","citation_count":18,"is_preprint":false},{"pmid":"17166517","id":"PMC_17166517","title":"Investigation of the G protein subunit Galphaolf gene (GNAL) in attention deficit/hyperactivity disorder.","date":"2006","source":"Journal of psychiatric research","url":"https://pubmed.ncbi.nlm.nih.gov/17166517","citation_count":18,"is_preprint":false},{"pmid":"24408567","id":"PMC_24408567","title":"Screening of mutations in GNAL in sporadic dystonia patients.","date":"2014","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/24408567","citation_count":15,"is_preprint":false},{"pmid":"24729450","id":"PMC_24729450","title":"De novo mutation in the GNAL gene causing seemingly sporadic dystonia in a Serbian patient.","date":"2014","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/24729450","citation_count":12,"is_preprint":false},{"pmid":"31034808","id":"PMC_31034808","title":"Gnal haploinsufficiency causes genomic instability and increased sensitivity to haloperidol.","date":"2019","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/31034808","citation_count":11,"is_preprint":false},{"pmid":"26810727","id":"PMC_26810727","title":"Screening of GNAL variants in Brazilian patients with isolated dystonia reveals a novel mutation with partial loss of function.","date":"2016","source":"Journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/26810727","citation_count":11,"is_preprint":false},{"pmid":"38182074","id":"PMC_38182074","title":"Loss-of-function of GNAL dystonia gene impairs striatal dopamine receptors-mediated adenylyl cyclase/ cyclic AMP signaling pathway.","date":"2024","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/38182074","citation_count":8,"is_preprint":false},{"pmid":"15908736","id":"PMC_15908736","title":"G-protein Golfalpha (GNAL) is expressed in the vestibular end organs and primary afferent neurons of Rattus norvegicus.","date":"2005","source":"Journal of vestibular research : equilibrium & orientation","url":"https://pubmed.ncbi.nlm.nih.gov/15908736","citation_count":7,"is_preprint":false},{"pmid":"18842685","id":"PMC_18842685","title":"Wheels within wheels: clues to the evolution of the Gnas and Gnal loci.","date":"2008","source":"Molecular biology and evolution","url":"https://pubmed.ncbi.nlm.nih.gov/18842685","citation_count":7,"is_preprint":false},{"pmid":"11474171","id":"PMC_11474171","title":"C18orf2, a novel, highly conserved intronless gene within intron 5 of the GNAL gene on chromosome 18p11.","date":"2001","source":"Cytogenetics and cell genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11474171","citation_count":5,"is_preprint":false},{"pmid":"33175450","id":"PMC_33175450","title":"Mutational spectrum of GNAL, THAP1 and TOR1A genes in isolated dystonia: study in a population from Spain and systematic literature review.","date":"2020","source":"European journal of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/33175450","citation_count":3,"is_preprint":false},{"pmid":"38686055","id":"PMC_38686055","title":"Multi-cohort comprehensive analysis unveiling the clinical value and therapeutic effect of GNAL in glioma.","date":"2024","source":"Oncology research","url":"https://pubmed.ncbi.nlm.nih.gov/38686055","citation_count":3,"is_preprint":false},{"pmid":"39253490","id":"PMC_39253490","title":"Conditional Knockout of Striatal Gnal Produces Dystonia-like Motor Phenotypes.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/39253490","citation_count":2,"is_preprint":false},{"pmid":"40902679","id":"PMC_40902679","title":"Characterization of mice with cell type-specific Gnal loss of function provides insights on GNAL-linked dystonia.","date":"2025","source":"Neurobiology of disease","url":"https://pubmed.ncbi.nlm.nih.gov/40902679","citation_count":2,"is_preprint":false},{"pmid":"35396637","id":"PMC_35396637","title":"A new mutation in the GNAL gene in familial dystonia presenting with mental symptoms.","date":"2022","source":"Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology","url":"https://pubmed.ncbi.nlm.nih.gov/35396637","citation_count":0,"is_preprint":false},{"pmid":"40909808","id":"PMC_40909808","title":"Mouse Gnal transcripts and transcriptomics in isolated dystonia.","date":"2025","source":"Research square","url":"https://pubmed.ncbi.nlm.nih.gov/40909808","citation_count":0,"is_preprint":false},{"pmid":"41387123","id":"PMC_41387123","title":"The Gut Microbiota Regulates Motor Deficits via Butyrate in a Gnal+/- Mouse Model of DYT25 Dystonia.","date":"2025","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/41387123","citation_count":0,"is_preprint":false},{"pmid":"41632233","id":"PMC_41632233","title":"Long-term efficiency of pallidal DBS and the role of Levodopa treatment in DYT-GNAL and 18p deletion syndrome associated dystonia: an observational study and review of literature.","date":"2026","source":"Journal of neural transmission (Vienna, Austria : 1996)","url":"https://pubmed.ncbi.nlm.nih.gov/41632233","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.07.02.662743","title":"Characterization of mice with cell type-specific <i>Gnal</i> loss of function provides insights on <i>GNAL</i>-linked dystonia","date":"2025-07-03","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.02.662743","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.07.20.665815","title":"Molecular unbalances between striosome and matrix compartments characterize the pathogenesis of Huntington’s disease model mouse","date":"2025-07-24","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.20.665815","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.04.13.648593","title":"Developmental, neuroanatomical and cellular expression of genes causing dystonia","date":"2025-04-18","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.13.648593","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.06.30.662485","title":"Wnt-3a exacerbates production of TNF-α in LPS stimulated microglia independent of the β-catenin canonical pathway","date":"2025-07-04","source":"bioRxiv","url":"https://doi.org/10.1101/2025.06.30.662485","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.12.02.24316741","title":"Genetic Diversity and Expanded Phenotypes in Dystonia: Insights from Large-Scale Exome Sequencing","date":"2024-12-05","source":"bioRxiv","url":"https://doi.org/10.1101/2024.12.02.24316741","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.07.18.665513","title":"Transcriptional Circuitry in HGSOC: A Dynamic Three-State Model Informed by a Living Biobank of Purified Tumour Fractions","date":"2025-07-22","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.18.665513","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":18930,"output_tokens":2209,"usd":0.044963},"stage2":{"model":"claude-opus-4-6","input_tokens":5571,"output_tokens":2423,"usd":0.132645},"total_usd":0.177608,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2012,\n      \"finding\": \"Loss-of-function mutations in GNAL (encoding Gαolf) cause primary torsion dystonia; impaired coupling of Gαolf to downstream signaling was demonstrated using bioluminescence resonance energy transfer (BRET) assays for multiple missense and nonsense mutations.\",\n      \"method\": \"BRET assay (functional coupling assay), exome sequencing, Sanger sequencing\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — functional BRET assay with multiple mutations, replicated across multiple subsequent studies\",\n      \"pmids\": [\"23222958\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"GNAL missense mutations p.Gly213Ser and p.Ala353Thr impair Gαolf coupling to dopamine D1 receptors, as measured by BRET assay; variants with normal BRET responses (p.Ala311Thr) were classified as benign.\",\n      \"method\": \"BRET assay measuring Gαolf–D1 receptor coupling\",\n      \"journal\": \"JAMA neurology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — direct functional assay, orthogonal to initial discovery paper\",\n      \"pmids\": [\"24535567\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"GNAL encodes two isoforms of Gαolf via alternative first exons with different CNS expression patterns; both isoforms functionally couple to the dopamine D1 receptor when heterologously expressed in Sf9 cells.\",\n      \"method\": \"5' RACE, heterologous expression in Sf9 cells, functional coupling assay\",\n      \"journal\": \"Molecular psychiatry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional coupling shown in heterologous system, single lab\",\n      \"pmids\": [\"16044173\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Heterozygous Gnal knockout mice (Gnal+/-) exhibit altered striatal spine morphology and phospho-CaMKIIβ levels, and develop dystonia-like movements after striatal (but not cerebellar) oxotremorine infusion, placing GNAL-dependent cAMP signaling in striatal projection neurons as a key locus for dystonia; muscarinic M1 antagonists prevented these movements.\",\n      \"method\": \"Heterozygous knockout mouse model, intrastriatal drug infusion, EEG, pharmacological rescue (telenzepine, trihexyphenidyl), operant conditioning, spine morphology analysis\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods, clear loss-of-function phenotype with pharmacological rescue, striatum-specific localization of effect\",\n      \"pmids\": [\"28546310\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"A novel GNAL variant (p.F133L) causes elevated basal BRET signal and severely diminished amplitude of response to dopamine stimulation, indicating partial Gαolf loss of function in receptor signal transduction.\",\n      \"method\": \"BRET assay with dopamine stimulation\",\n      \"journal\": \"Journal of neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct functional assay, single lab, single variant\",\n      \"pmids\": [\"26810727\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Gnal haploinsufficiency (Gnal+/- mice) increases catalepsy responses to haloperidol (D2R blocker), causes persistent DNA breaks, decreases cAMP-dependent histone H3 phosphorylation (Ser10), and increases cell death in the striatum; aged Gnal+/- mice show increased global DNA methylation and dendritic structural abnormalities, demonstrating that Gαolf deficiency intensifies the cellular effects of D2R antagonism.\",\n      \"method\": \"Heterozygous knockout mouse model, behavioral testing (catalepsy), immunostaining (histone H3 pSer10), DNA damage assays, methylation analysis, dendritic morphology\",\n      \"journal\": \"Experimental neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal readouts in a defined genetic model, single lab\",\n      \"pmids\": [\"31034808\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"In Gnal+/- rats, A2A receptor (A2AR) total protein levels are increased while adenylyl cyclase 5 (AC5) is reduced; D2 receptor (D2R) protein and its regulatory proteins (RGS9-2, spinophilin, Gβ5, β-arrestin2) are also reduced, and D2R-mediated inhibitory responses in striatal cholinergic interneurons are attenuated, demonstrating a profound disruption of the A2AR/D2R–AC–cAMP cascade downstream of Gαolf loss.\",\n      \"method\": \"Rat Gnal+/- model, Western blot (receptor and signaling protein quantification), whole-cell patch clamp electrophysiology (D2R-mediated inhibition of cholinergic interneurons)\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — combined biochemical and electrophysiological approach, multiple orthogonal methods, defined genetic model\",\n      \"pmids\": [\"38182074\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Conditional knockout of Gnal specifically in striatal neurons produces overt dystonia-like motor phenotypes (hindlimb clasping, torticollis, reduced coordination) and increases intrinsic excitability of striatal spiny projection neurons, directly linking striatal Gαolf loss to dystonia via homeostatic increases in neuronal excitability.\",\n      \"method\": \"Conditional knockout mouse (Gnal fl/fl + Cre), AAV-Cre delivery, motor behavioral testing, ex vivo whole-cell patch clamp electrophysiology\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — well-controlled genetic model with behavioral and electrophysiological readouts, preprint only\",\n      \"pmids\": [\"39253490\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Cell-type-specific conditional deletion of Gnal in D1-receptor-expressing striatal projection neurons (D1-SPNs) confirms Gαolf is required for adenylyl cyclase 5 activation and coupling with D1 receptors; loss in D1-SPNs causes motor deficits and nocturnal hyperactivity but not overt dystonia. Loss in A2A-receptor-expressing SPNs (A2A-SPNs) impairs coupling with A2A receptors and strikingly increases spontaneous locomotion not further enhanced by psychostimulants.\",\n      \"method\": \"Cell-type-specific conditional knockout mice (D1-Cre and A2A-Cre × Gnal fl/fl), motor behavioral testing, pharmacological challenges (D1 agonists, psychostimulants, caffeine, KW6002), biochemical measurements of adenylyl cyclase 5 activity\",\n      \"journal\": \"Neurobiology of disease\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific genetic dissection with multiple pharmacological and behavioral readouts, reciprocal genetic and biochemical validation\",\n      \"pmids\": [\"40902679\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GNAL encodes Gαolf, a stimulatory G-protein α subunit enriched in striatal projection neurons and olfactory tissue that couples dopamine D1 and adenosine A2A receptors to adenylyl cyclase 5, thereby driving cAMP production; loss-of-function mutations impair this receptor–adenylyl cyclase coupling (shown by BRET and electrophysiological assays), reduce downstream cAMP-dependent signaling and D2R regulatory mechanisms, and increase intrinsic excitability of striatal spiny projection neurons, collectively producing the dystonia motor phenotype associated with DYT-GNAL/DYT25.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GNAL encodes Gαolf, a stimulatory G-protein α subunit enriched in striatal projection neurons and olfactory epithelium that couples dopamine D1 and adenosine A2A receptors to adenylyl cyclase 5 to drive cAMP production. Two Gαolf isoforms generated by alternative first exons both functionally couple to the D1 receptor, and loss-of-function mutations impair this coupling as demonstrated by BRET assays across multiple variants [PMID:23222958, PMID:24535567, PMID:16044173]. Gαolf haploinsufficiency in rodent models disrupts the A2AR/D2R–AC5–cAMP signaling cascade, reduces D2R regulatory protein levels, attenuates D2R-mediated inhibitory responses in striatal cholinergic interneurons, and increases intrinsic excitability of spiny projection neurons, with cell-type-specific deletion demonstrating that Gαolf loss in D1-SPNs impairs D1R–AC5 coupling while loss in A2A-SPNs eliminates A2AR-mediated signaling and produces spontaneous hyperlocomotion [PMID:38182074, PMID:40902679, PMID:28546310]. Loss-of-function mutations in GNAL cause primary torsion dystonia (DYT25/DYT-GNAL), with striatal neurons confirmed as the critical locus through region- and cell-type-specific genetic models [PMID:23222958, PMID:28546310, PMID:40902679].\",\n  \"teleology\": [\n    {\n      \"year\": 2005,\n      \"claim\": \"Resolving whether GNAL produces a single or multiple protein isoforms revealed two Gαolf variants with distinct CNS expression patterns, both capable of coupling to D1 receptors, establishing isoform diversity as a feature of GNAL signaling.\",\n      \"evidence\": \"5′ RACE and heterologous expression/functional coupling in Sf9 cells\",\n      \"pmids\": [\"16044173\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single-lab heterologous system; coupling not confirmed in native striatal neurons\", \"Isoform-specific functional differences in vivo remain undefined\", \"Relative contribution of each isoform to striatal cAMP signaling unknown\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"The central question of whether GNAL mutations cause human dystonia was answered by identifying loss-of-function mutations in dystonia families and demonstrating impaired Gαolf–downstream coupling via BRET, establishing GNAL as a dystonia gene (DYT25).\",\n      \"evidence\": \"Exome/Sanger sequencing in dystonia families combined with BRET functional assays for multiple missense and nonsense mutations\",\n      \"pmids\": [\"23222958\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which partial Gαolf loss produces dystonia rather than other movement disorders was unknown\", \"Downstream effector (AC5 vs other cyclases) not yet specified in these assays\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Extending the BRET-based functional framework to additional GNAL variants enabled discrimination of pathogenic from benign missense changes, confirming that impaired D1R coupling is the shared molecular defect.\",\n      \"evidence\": \"BRET assay measuring Gαolf–D1 receptor coupling for p.Gly213Ser, p.Ala353Thr (impaired) vs. p.Ala311Thr (normal)\",\n      \"pmids\": [\"24535567\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether coupling defects are equivalent for A2A receptor was not tested\", \"Protein stability vs. coupling defect not distinguished for each variant\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"A variant (p.F133L) showing elevated basal BRET signal with severely diminished dopamine-stimulated response demonstrated that partial loss of function—not just complete loss—of Gαolf receptor coupling is pathogenic.\",\n      \"evidence\": \"BRET assay with dopamine stimulation for a single novel variant\",\n      \"pmids\": [\"26810727\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Single variant from one laboratory\", \"Whether elevated basal signal reflects constitutive activity or misfolding was not resolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Whether dystonia originates from striatal or cerebellar Gαolf deficiency was resolved: Gnal+/− mice developed dystonia-like movements only after intrastriatal (not cerebellar) muscarinic challenge, and anticholinergics rescued the phenotype, placing the striatum as the critical locus and implicating cholinergic imbalance.\",\n      \"evidence\": \"Heterozygous Gnal knockout mice, region-specific drug infusion, pharmacological rescue, spine morphology and phospho-CaMKIIβ analysis\",\n      \"pmids\": [\"28546310\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Pharmacological trigger required to unmask phenotype—spontaneous dystonia not observed in heterozygotes\", \"Cell-type specificity within the striatum not yet resolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Beyond acute signaling, Gαolf haploinsufficiency was shown to produce long-term cellular consequences including persistent DNA breaks, reduced cAMP-dependent histone H3 phosphorylation, increased DNA methylation, and dendritic abnormalities, revealing that chronic Gαolf deficiency causes epigenomic and structural neuronal damage.\",\n      \"evidence\": \"Gnal+/− mice with immunostaining (H3 pSer10), DNA damage assays, methylation analysis, dendritic morphology, and haloperidol-induced catalepsy\",\n      \"pmids\": [\"31034808\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Causal chain from reduced cAMP to DNA damage and methylation changes not established\", \"Single laboratory study\", \"Whether epigenomic changes are cell-type-specific not determined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"The full scope of signaling cascade disruption downstream of Gαolf loss was characterized: Gnal+/− rats showed increased A2AR but decreased AC5, D2R, and D2R-associated regulatory proteins (RGS9-2, spinophilin, β-arrestin2), with electrophysiologically confirmed attenuation of D2R-mediated inhibition in cholinergic interneurons.\",\n      \"evidence\": \"Gnal+/− rat model with Western blot quantification and whole-cell patch-clamp electrophysiology of striatal cholinergic interneurons\",\n      \"pmids\": [\"38182074\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether compensatory A2AR upregulation is functionally protective or maladaptive is unclear\", \"Mechanism of D2R and associated protein downregulation not defined\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Cell-type-specific deletion resolved the distinct contributions of Gαolf in D1-SPNs versus A2A-SPNs: loss in D1-SPNs impairs D1R–AC5 coupling causing motor deficits without overt dystonia, while loss in A2A-SPNs eliminates A2AR signaling and produces striking hyperlocomotion insensitive to psychostimulants, demonstrating that Gαolf is independently required in both SPN populations for distinct motor functions.\",\n      \"evidence\": \"Cell-type-specific conditional knockout mice (D1-Cre and A2A-Cre × Gnal fl/fl) with pharmacological challenges and AC5 activity measurements\",\n      \"pmids\": [\"40902679\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Neither single cell-type deletion fully recapitulated DYT-GNAL dystonia, suggesting combinatorial loss may be required\", \"Whether Gαolf loss in striatal interneurons contributes to dystonia is untested\", \"Circuit-level mechanisms linking SPN excitability changes to dystonic movements remain unresolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How partial Gαolf loss in specific striatal cell types converges at the circuit level to produce dystonic movements—and why haploinsufficiency is sufficient in humans but requires pharmacological provocation or complete knockout in rodents—remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No structural model of Gαolf explaining variant-specific coupling defects\", \"Whether Gαolf interacts with additional GPCRs beyond D1R and A2AR in striatum is unexplored\", \"Therapeutic restoration of Gαolf signaling has not been demonstrated in any model\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [0, 1, 2, 4, 8]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 1, 2, 6]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0162582\", \"supporting_discovery_ids\": [0, 1, 2, 6, 8]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [3, 6, 7, 8]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"DRD1\", \"ADORA2A\", \"ADCY5\", \"RGS9-2\", \"GNB5\"],\n    \"other_free_text\": []\n  }\n}\n```"}